Last reviewed · How we verify
Mannitol 20% Infusion — Competitive Intelligence Brief
phase 3
Osmotic diuretic
Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
Mannitol 20% Infusion (Mannitol 20% Infusion) — Centre Hospitalier Universitaire de Besancon. Mannitol is an osmotic diuretic that draws fluid from tissues into the intravascular space and increases urine output to reduce intracranial pressure and cerebral edema.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mannitol 20% Infusion TARGET | Mannitol 20% Infusion | Centre Hospitalier Universitaire de Besancon | phase 3 | Osmotic diuretic | ||
| Aridol Kit | Mannitol | Baxter | marketed | Osmotic diuretic | Glomerular filtrate osmolarity; tubular reabsorption of water | 1964-01-01 |
| Aridol Kit | MANNITOL | Baxter | marketed | Osmotic Diuretic [EPC] | sodium channels | 1964-01-01 |
| Aridol Kit | Mannitol | Baxter | marketed | Osmotic diuretic | Glomerular filtrate osmolarity; tubular reabsorption of water | 1964-01-01 |
| Aridol Kit | Mannitol | Baxter | marketed | Osmotic diuretic | Glomerular filtrate osmolarity; tubular reabsorption of water | 1964-01-01 |
| Mannitol | Mannitol | Baxter | marketed | Osmotic diuretic | Glomerular filtrate osmolarity; intracellular water movement | 1964-01-01 |
| i.v. mannitol | i.v. mannitol | University Hospital, Saarland | marketed | Osmotic diuretic |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Osmotic diuretic class)
- Baxter · 4 drugs in this class
- Centre Hospitalier Universitaire de Besancon · 1 drug in this class
- Pfizer Inc. · 1 drug in this class
- Thiogenesis Therapeutics, Inc. · 1 drug in this class
- University Hospital, Grenoble · 1 drug in this class
- University Hospital, Saarland · 1 drug in this class
- Ain Shams University · 1 drug in this class
- University of Aarhus · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mannitol 20% Infusion CI watch — RSS
- Mannitol 20% Infusion CI watch — Atom
- Mannitol 20% Infusion CI watch — JSON
- Mannitol 20% Infusion alone — RSS
- Whole Osmotic diuretic class — RSS
Cite this brief
Drug Landscape (2026). Mannitol 20% Infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/mannitol-20-infusion. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab